Our results suggested that the proportion of CD4+ and CD8+ T lymphocytes and CD4+:CD8+ T ratio has shown slight changes in both lymph nodes and peripheral blood between the treatment groups and the T2DM group. Here, CD8A is linked to type 2 diabetes mellitus.